CoChat

Bcl-3 induced by IL-22 via STAT3 activation acts as a potentiator of psoriasis-related gene expression in epidermal keratinocytes

Open access

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

IL-22 induces STAT3 phosphorylation and mediates psoriasis-related gene expression. However, the signaling mechanism leading from pSTAT3 to the expression of these genes remains unclear. We focused on Bcl-3, which is induced by STAT3 activation and mediates gene expression. In cultured human epidermal keratinocytes, IL-22 increased Bcl-3, which was translocated to the nucleus with p50 via STAT3 activation. The increases in CXCL8, S100As and human β-defensin 2 mRNA expression caused by IL-22 were abolished by siRNA against Bcl-3. Although CCL20 expression was also augmented by IL-22, the knockdown of Bcl-3 increased its level. Moreover, the combination of IL-22 and IL-17A enhanced Bcl-3 production, IL-22-induced gene expression, and the expression of other psoriasis-related genes, including those encoding IL-17C, IL-19, and IL-36γ. The expression of these genes (except for CCL20) was also suppressed by the knockdown of Bcl-3. Bcl-3 overexpression induced CXCL8 and HBD2 expression but not S100As expression. We also compared Bcl-3 expression between psoriatic skin lesions and normal skin. Immunostaining revealed strong signals for Bcl-3 and p50 in the nucleus of epidermal keratinocytes from psoriatic skin. The IL-22-STAT3-Bcl-3 pathway may be important in the pathogenesis of psoriasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.201747017

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. C 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu 15214141, 2018, 1, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/eji.201747017 by Readcube (Labtiva Inc.), Wiley Online Library on [21/08/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

Cited by

See all 46

Metadata

Authors
Tohyama, M., Shirakata, Y., Hanakawa, Y., Dai, X., Shiraishi, K., Murakami, M., Miyawaki, S., Mori, H., Utsunomiya, R., Masuda, K., Hashimoto, K., & Sayama, K.
Affiliations
Ehime University (JP)
Corresponding author
Tohyama, Mikiko
Venue
European Journal of Immunology
Publisher
Wiley
Published
2017-11-20
Volume
48
Issue
1
Pages
168-179
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2754930357
Cited by
41
References
50
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 10 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 1
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • European Journal of Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Osaka University
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Keywords
Bcl-3, IL-22, STAT3 activation, psoriasis, epidermal keratinocytes, P50, interleukin-8, human beta-defensin 2, S100A, CCL20, IL-17A, IL-17C, IL-19, IL-36γ, psoriatic lesions, transcriptional regulation
MeSH terms
B-Cell Lymphoma 3 Protein, Interleukin-22, Cells, Cultured, Enzyme Activation, Gene Expression Regulation, Humans, Interleukin-1, Interleukins, S100 Proteins, Phosphorylation, Proto-Oncogene Proteins, Psoriasis, RNA, Messenger, Skin, Transcription Factors, Keratinocytes, Interleukin-8, Interleukin-17, Active Transport, Cell Nucleus, beta-Defensins, RNA Interference, RNA, Small Interfering, STAT3 Transcription Factor, NF-kappa B p50 Subunit, Chemokine CCL20

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.